Management of Toxicological Emergencies in the School Setting: An Overview for School Nurses Part 2

Abstract

School nurses may encounter a variety of poisoning and overdose scenarios in the school setting. Youth have an increased risk for harm due to factors associated with substance use, self-harm, and exposure to more toxic ingestants. Poison Control Centers are uniquely qualified to assist the public and health professionals, including school nurses, with poisoning and overdose incidents and are available 24 hours per day. This article is Part 2 of a series of three articles and focuses on poisonings related to substances of abuse and addiction or as a result of social media challenges. Information includes expected clinical effects, potential for serious injury, and a reasonable approach to manage these exposures for the following substances of potential harm: alcohol, caffeine, dextromethorphan, inhalants, marijuana, tobacco, and nicotine replacement therapy. Part 3 of the series will discuss potential environmental hazards specific to the school setting.

Keywords

toxicology Regional Poison Control Center school nurses alcohol caffeine dextromethorphan inhalants marijuana nicotine replacement social media challenges

Get full access to this article

View all access options for this article.

References

Benowitz

N. L.

(2018). Nicotine. In Olson

(Ed.), Poisoning and Drug Overdose7th ed . (pp. 337–339). McGraw Hill.

Centers for Disease Control and Prevention. (2021, September 30). Youth e-cigarette use remains serious public health concern amid COVID-19 pandemic. CDC Newsroom. https://www.cdc.gov/media/releases/2021/p0930-e-cigarette.html

Dharmapuri

Miller

Klein

J. D.

(2020). Marijuana and the pediatric population. Pediatrics, 146(2), 2019–2068. https://doi.org/10.1542/peds.2019-2629

Gummin

D. D.

Mowry

J. B.

Beuhler

M. C.

Spyker

D. A.

Brooks

D. E.

Dibert

K. W.

Rivers

L. J.

Pham

N. P. T.

Ryan

M. L.

(2019). 2019 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS) (37th annual report, clinical toxicology. 12, 1494). https://doi.org/10.1080/15563650.2020.1834219

IBM Micromedex® POISINDEX®. (2021a). Alcohols-clinical effects. https://www.micromedexsolutions.com

IBM Micromedex® POISINDEX®. (2021b). Alcohols-range of toxicity. https://www.micromedexsolutions.com/

IBM Micromedex® POISINDEX®. (2021c). Caffeine-range of toxicity. https://www.micromedexsolutions.com/

IBM Micromedex® POISINDEX®. (2021d). Dextromethorphan-range of toxicity. https://www.micromedexsolutions.com/

IBM Micromedex® POISINDEX®. (2021e). Fluroinated hydrocarbons-treatment. https://www.micromedexsolutions.com

10.

Long

(2019). Inhalants. In Nelson

L. S.

Howland

Lewin

N. A.

Smith

S. W.

Goldfrank

L. R.

Hoffman

R. S.

(Eds.). https://accesspharmacy.mhmedical.com/content.aspx?bookid=2569&sectionid=210260247

11.

National Association of School Nurses. (2021a, May 3). NASN statement on FDA rulemaking to prohibit sale of menthol cigarettes. https://www.nasn.org/blogs/nasn-profile/2021/05/03/nasn-statement-on-fda-rulemaking-to-prohibit-sale

12.

National Association of School Nurses. (2021b). Vanquishing vaping toolkit. https://pathlms.com/nasn/courses/35289

13.

National Institute on Drug Abuse. (2021, December). Monitoring the future 2020 survey results. http://monitoringthefuture.org/data/21data/Inhalants/Inhalants_jsFigures.htm

14.

Pourseyed

L. M.

Torres

Hooker

Fowlie

Young

Seyfoddin

(2020). Methods for quantification of cannabinoids: A narrative review. Journal of Cannabis Research, 2(1), Article 35. https://doi.org/10.1186/s42238-020-00040-2

15.

Richards

J. R.

(2018). Cannabinoid hyperemesis syndrome: Pathophysiology and treatment in the emergency department. The Journal of Emergency Medicine, 54(3), 354–363. https://doi.org/10.1016/j.jemermed.2017.12.010

16.

Richards

J. R.

Smith

N. E.

Moulin

A. K.

(2017). Unintentional cannabis ingestion in children: A systematic review. The Journal of Pediatrics, 190, 142–152. https://doi.org/10.1016/j.jpeds.2017.07.005

17.

Schoedel

K. A.

Szeto

Setnik

Sellers

E. M.

Levy-Cooperman

Mills

Etges

Sommerville

(2018). Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial. Epilepsy & Behavior: E&B, 88, 162–171. https://doi.org/10.1016/j.yebeh.2018.07.027

18.

State Tobacco Activities Tracking and Evaluation System. (2021, September 30). STATE system e-cigarette fact sheet. Centers for Disease Control and Prevention. https://www.cdc.gov/statesystem/factsheets/ecigarette/ECigarette.html

19.

Taylor

B. N.

Mueller

Sauls

R. S.

(2021, August 25). Cannabinoid antiemetic therapy. In Statpearls [Internet]. Statpearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK535430/

20.

U.S. Drug Enforcement Administration. (2020a, April). Drug fact sheet-DXM. https://www.dea.gov/sites/default/files/2020-06/DXM-2020.pdf

21.

U.S. Drug Enforcement Administration. (2020b, April). Drug fact sheet-Marijuana/Cannabis. https://www.dea.gov/sites/default/files/2020-06/Marijuana-Cannabis-2020_0.pdf

22.

U.S. Food and Drug Administration. (2018a). Epidiolex® package insert. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210365lbl.pdf

23.

U.S. Food and Drug Administration. (2018b). Spilling the beans: How much caffeine is too much?. https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much

24.

U.S. Food and Drug Administration. (2020a, January 2). FDA finalizes enforcement policy on unauthorized flavored cartridge-based e-cigarettes that appeal to children, including fruit and mint. https://www.fda.gov/news-events/press-announcements/fda-finalizes-enforcement-policy-unauthorized-flavored-cartridge-based-e-cigarettes-appeal-children

25.

U.S. Food and Drug Administration. (2020b, May 28). Tobacco products: Products, ingredients and components. https://www.fda.gov/tobacco-products/products-guidance-regulations/products-ingredients-components

26.

White

N. D.

(2017). Alcohol use in young adults with type 1 diabetes mellitus. American Journal of Lifestyle Medicine, 11(6), 433–435. https://doi.org/10.1177/1559827617722137

27.

Yip

(2019). Ethanol. In Nelson

L. S.

Howland

Lewin

N. A.

Smith

S. W.

Goldfrank

L. R.

Hoffman

R. S.

(Eds.). https://accesspharmacy.mhmedical.com/content.aspx?bookid=2569&sectionid=210259873